There are several renal syndromes that are unique to patients with cancer, being caused either by the cancer itself or by its treatment. This Review provides nephrologists—who are essential members of the multidisciplinary team that cares for patients with malignancy—with an overview of these syndromes. The article is divided into sections that deal with the renal impact of different cancer types, interventions, and commonly used chemotherapeutic and biological agents.
- Kevin W Finkel
- John R Foringer
